Manufacturing SOP creation is breaking down as critical process knowledge remains trapped in training videos and ...
Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Farmland is at risk from the rapid expansion in solar energy due to “inconsistencies” in Environmental Impact Assessments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results